FDA Approves Opvee

May 22, 2023 0

FDA Approves Opvee (nalmefene hydrochloride) Prescription Nasal Spray to Reverse Opioid Overdose May 22, 2023 — Today, the U.S. Food and Drug Administration approved Opvee, […]

FDA Approves Arexvy

May 4, 2023 0

FDA Approves Arexvy (respiratory syncytial virus vaccine, adjuvanted) Respiratory Syncytial Virus (RSV) Vaccine for Older Adults May 3, 2023 — GSK plc (LSE/NYSE: GSK) today […]

FDA Approves Abilify Asimtufii

May 2, 2023 0

FDA Approves Abilify Asimtufii (aripiprazole) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of Bipolar I Disorder in Adults April 28, 2023 — Otsuka […]

FDA Approves Joenja

March 27, 2023 0

FDA Approves Joenja (leniolisib) for the Treatment of Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) LEIDEN, The Netherlands, March 24, 2023 /PRNewswire/ — Pharming Group N.V. […]

FDA Approves Rezzayo

March 24, 2023 0

FDA Approves Rezzayo (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis SAN DIEGO & PARSIPPANY, N.J.–(BUSINESS WIRE)– March 22, 2023 — Cidara […]